Clinician Scientist
Website:

Relevant NGDI Articles

2013

Measuring maternal health: focus on maternal morbidity. Firoz T, Chou D, von Dadelszen P, Agrawal P, Vanderkruik R, Tunçalp O, Magee LA, van Den Broek N, Say L; Maternal Morbidity Working Group. Bull World Health Organ. 2013 Oct 1;91(10):794-6.

Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists. Lalani S, Firoz T, Magee LA, Sawchuck D, Payne B, Gordon R, Vidler M, von Dadelszen P. J Obstet Gynaecol Can. 2013 Mar;35(3):215-23.

2012

Magnesium sulphate for prevention and treatment of eclampsia in low and middle income countries: Systematic review of tested regimens. Gordon RM, Payne B, Firoz T, Magee L, Sawchuck D, Tu D, Vidler M and von Dadelszen P.  Pregnancy Hypertens 2012 2(3):328.

Oral antihypertensive therapy for severe hypertension in pregnancy. Firoz T, Magee LA, Lalani S, Sawchuck D, Payne B, Vidler M, Gordon R and von Dadelszen P.  Pregnancy Hypertens 2012 2(3):288.

Pharmacotherapy for pre-eclampsia in low and middle income countries: An analysis of essential medicines lists (EMLS). Lalani S, Firoz T, Magee LA, Lowe R, Sawchuck D, Payne B, Gordon R, Vidler M and von Dadelszen P. Pregnancy Hypertens 2012 2(3):193-194.

The PIERS experience: research or quality improvement? Firoz T, Magee LA, Payne BA, Menzies JM and von Dadelszen P. J Obstet Gynaecol Can  2012 34(4):379-381.

2011

Pre-eclampsia in low and middle income countries. Best practice & research. Firoz T, Sanghvi H, Merialdi M, and von Dadelszen P. Clinical Obstetrics & Gynaecology 2011, Vol25:4:537-548.